Directing cell therapy to anatomic target sites in vivo with magnetic resonance targeting

Nature Communications

Volumn 6, Issue , 2015, Pages

  Muthana, Munitta ^a   Kennerley, Aneurin J ^a   Hughes, Russell ^a   Fagnano, Ester ^a   Richardson, Jay ^a   Paul, Melanie ^a   Murdoch, Craig ^a   Wright, Fiona ^a   Payne, Christopher ^b   Lythgoe, Mark F ^b   Farrow, Neil ^c   Dobson, Jon ^d   Conner, Joe ^e   Wild, Jim M ^a   Lewis, Claire ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c KEELE UNIVERSITY   (United Kingdom)

^d J Crayton Pruitt Family Department of Biomedical Engineering   (United States)

^e SORRENTO THERAPEUTICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOLYTIC VIRUS; SEPREHVIR; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; UNCLASSIFIED DRUG; CONTRAST MEDIUM; FERRIC ION; FERRIC OXIDE; GADOLINIUM PENTETATE; METAL NANOPARTICLE;

ANATOMY; CELLS AND CELL COMPONENTS; DISEASE TREATMENT; IRON OXIDE; NUCLEAR MAGNETIC RESONANCE; PARTICLE SIZE; TUMOR; VIRUS;

ANATOMICAL CONCEPTS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER LOCALIZATION; CELL INFILTRATION; CELL THERAPY; CONTROLLED STUDY; DISTANT METASTASIS; HUMAN; IN VIVO STUDY; LUNG METASTASIS; MACROPHAGE; MAGNETIC FIELD; MALE; MOLECULARLY TARGETED THERAPY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE SCANNER; ONCOLYTIC VIROTHERAPY; TARGET ORGAN; TUMOR VOLUME; ANIMAL; BIOLOGICAL THERAPY; CAPILLARY PERMEABILITY; CELL CULTURE; NEOPLASMS, EXPERIMENTAL; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHYSIOLOGY; PROSTATIC NEOPLASMS; RANDOMIZATION; XENOGRAFT;

MUS;

ANIMALS; CAPILLARY PERMEABILITY; CELL- AND TISSUE-BASED THERAPY; CELLS, CULTURED; CONTRAST MEDIA; FERRIC COMPOUNDS; GADOLINIUM DTPA; HUMANS; MACROPHAGES; MAGNETIC RESONANCE SPECTROSCOPY; MALE; METAL NANOPARTICLES; MICE; NEOPLASMS, EXPERIMENTAL; ONCOLYTIC VIRUSES; PROSTATIC NEOPLASMS; RANDOM ALLOCATION; TRANSPLANTATION, HETEROLOGOUS;

EID: 84939621864     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms9009     Document Type: Article

References (32)

1. Syed, B. A. & Evans, J. B. Stem cell therapy market. Nat. Rev. Drug. Discov. 12, 185-186 (2013).
2. Kyrtatos, P. G. et al. Magnetic tagging increases delivery of circulating progenitors in vascular injury. JACC. Cardiovasc. Interv. 2, 794-802 (2009).
3. Arbab, A. S. et al. In vivo trafficking and targeted delivery of magnetically labeled stem cells. Hum. Gene Ther. 15, 351-360 (2004).
4. Riegler, J. et al. Targeted magnetic delivery and tracking of cells using a magnetic resonance imaging system. Biomaterials 31, 5366-5371 (2010).
5. Landazuri, N. et al. Magnetic targeting of human mesenchymal stem cells with internalized superparamagnetic iron oxide nanoparticles. Small 9, 4017-4026 (2013).
6. Riegler, J. et al. Superparamagnetic iron oxide nanoparticle targeting of MSCs in vascular injury. Biomaterials 34, 1987-1994 (2013).
7. Muthana, M. et al. A novel magnetic approach to enhance the efficacy of cell-based gene therapies. Gene Ther. 15, 902-910 (2008).
8. Yellen, B. B., Hovorka, O. & Friedman, G. Arranging matter by magnetic nanoparticle assemblers. Proc. Natl Acad. Sci. USA 102, 8860-8864 (2005).
9. Martel, S. et al. Medical and technical protocol for automatic navigation of a wireless device in the carotid artery of a living swine using a standard clinical MRI system. Med. Image Comput. Comput. Assist. Interv. 10, 144-152 (2007).
10. Chanu, A. & Martel, S. Real-time software platform design for in-vivo navigation of a small ferromagnetic device in a swine carotid artery using a magnetic resonance imaging system. Conf. Proc. IEEE Eng. Med. Biol. Soc. 2007, 6585-6588 (2007).
11. Surder, D. et al. Cell-based therapy for myocardial repair in patients with acute myocardial infarction: rationale and study design of the SWiss multicenter Intracoronary Stem cells Study in Acute Myocardial Infarction (SWISS-AMI). Am. Heart J. 160, 58-64 (2010).
12. Kim, B. G., Hwang, D. H., Lee, S. I., Kim, E. J. & Kim, S. U. Stem cell-based cell therapy for spinal cord injury. Cell Transplant. 16, 355-364 (2007).
13. Garbayo, E. et al. Neuroprotective properties of marrow-isolated adult multilineage-inducible cells in rat hippocampus following global cerebral ischemia are enhanced when complexed to biomimetic microcarriers. J. Neurochem. 119, 972-988 (2011).
14. Biju, K. C. et al. Bone marrow-derived microglia-based neurturin delivery protects against dopaminergic neurodegeneration in a mouse model of Parkinson's disease. Neurosci. Lett. 535, 24-29 (2013).
15. Magga, J. et al. Production of monocytic cells from bone marrow stem cells: therapeutic usage in Alzheimer's disease. J. Cell. Mol. Med. 16, 1060-1073 (2012).
16. De Palma, M. et al. Tumor-targeted interferon-alpha delivery by Tie2- expressing monocytes inhibits tumor growth and metastasis. Cancer cell 14, 299-311 (2008).
17. Muthana, M. et al. Use of macrophages to target therapeutic adenovirus to human prostate tumors. Cancer. Res. 71, 1805-1815 (2011).
18. Muthana, M. et al. Macrophage delivery of an oncolytic virus abolishes tumor regrowth and metastasis after chemotherapy or irradiation. Cancer Res. 73, 490-495 (2013).
19. Kandalaft, L. E., Powell, Jr D. J. & Coukos, G. A phase I clinical trial of adoptive transfer of folate receptor-alpha redirected autologous T cells for recurrent ovarian cancer. J. Transl. Med. 10, 157 (2012).
20. Kershaw, M. H. et al. A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancer. Clin. Cancer Res. 12, 6106-6115 (2006).
21. Engell-Noerregaard, L., Hansen, T. H., Andersen, M. H., Thor Straten, P. & Svane, I. M. Review of clinical studies on dendritic cell-based vaccination of patients with malignant melanoma: assessment of correlation between clinical response and vaccine parameters. Cancer Immunol. Immunother. 58, 1-14 (2009).
22. Bartholeyns, J., Lopez, M. & Andreesen, R. Adoptive immunotherapy of solid tumors with activated macrophages: experimental and clinical results. Anticancer Res. 11, 1201-1204 (1991).
23. Bartoleyns, J., Romet-Lemonne, J. L., Chokri, M. & Lopez, M. Immune therapy with macrophages: present status and critical requirements for implementation. Immunobiology 195, 550-562 (1996).
24. Studeny, M. et al. Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. Cancer Res. 62, 3603-3608 (2002).
25. Leek, R. D., Landers, R. J., Harris, A. L. & Lewis, C. E. Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breast. Br. J. Cancer 79, 991-995 (1999).
26. Burke, B. et al. Hypoxia-induced gene expression in human macrophages: implications for ischemic tissues and hypoxia-regulated gene therapy. Am. J. Pathol. 163, 1233-1243 (2003).
27. Nakasone, E. S. et al. Imaging tumor-stroma interactions during chemotherapy reveals contributions of the microenvironment to resistance. Cancer Cell 21, 488-503 (2012).
28. Branca, R. T. et al. Molecular MRI for sensitive and specific detection of lung metastases. Proc. Natl Acad. Sci. USA 107, 3693-3697 (2010).
29. Sorensen, A. et al. In vivo evaluation of a cancer therapy strategy combining HSV1716-mediated oncolysis with gene transfer and targeted radiotherapy. J. Nucl. Med. 53, 647-654 (2012).
30. Setsompop, K. et al. Pushing the limits of in vivo diffusion MRI for the Human Connectome Project. NeuroImage 80, 220-233 (2013).
31. Pike, M. M. et al. High-resolution longitudinal assessment of flow and permeability in mouse glioma vasculature: Sequential small molecule and SPIO dynamic contrast agent MRI. Magn. Res. Med. 61, 615-625 (2009).
32. Beauregard, D. A., Hill, S. A., Chaplin, D. J. & Brindle, K. M. The susceptibility of tumours to the antivascular drug combretastatin A4 phosphate correlates with vascular permeability. Cancer Res. 61, 6811-6815 (2001).